ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,438Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 1269

$954K Total Retail Price of All Prescriptions

Rank: 32 out of 1269

497 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 15,023 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 671 598 1 1
LEVOTHYROXINE SODIUM 646 599 2 4
FUROSEMIDE 579 526 3 5
AMLODIPINE BESYLATE 507 450 4 2
POTASSIUM CHLORIDE 454 417 5 26
METOPROLOL TARTRATE 434 408 6 6
CITALOPRAM HBR 410 372 7 21
SIMVASTATIN 403 375 8 3
OMEPRAZOLE 401 317 9 8
DONEPEZIL HCL 386 368 10 22
TRAZODONE HCL 347 314 11 36
METOPROLOL SUCCINATE 287 265 12 13
SERTRALINE HCL 266 252 13 23
METFORMIN HCL 204 175 14 9
NAMENDA 201 191 15 38
WARFARIN SODIUM 201 189 15 12
PAROXETINE HCL 185 158 17 71
ATORVASTATIN CALCIUM 183 159 18 7
LOSARTAN POTASSIUM 179 170 19 15
QUETIAPINE FUMARATE 177 165 20 53
PANTOPRAZOLE SODIUM 177 142 20 18
OXYCODONE-ACETAMINOPHEN 174 138 S2 22 44
CYMBALTA 160 103 23 70
RISPERIDONE 158 147 24 43
OXYBUTYNIN CHLORIDE 149 135 25 128
PLAVIX 148 133 26 47
TRAMADOL HCL 147 142 27 16
ESCITALOPRAM OXALATE 143 136 28 58
GLIPIZIDE 142 129 29 37
HYDROCODONE-ACETAMINOPHEN 140 93 S3 30 20
HYDROCHLOROTHIAZIDE 138 124 31 10
CLOPIDOGREL 137 121 32 32
RANITIDINE HCL 137 115 32 27
LEVOFLOXACIN 137 112 32 75
LOVASTATIN 135 111 35 30
SULFAMETHOXAZOLE-TRIMETHOPRIM 134 122 36 84
MIRTAZAPINE 126 115 37 24
ISOSORBIDE MONONITRATE ER 122 117 38 63
CLONIDINE HCL 122 99 38 51
CARBIDOPA-LEVODOPA 120 117 40 78
PRAVASTATIN SODIUM 115 92 41 11
AZITHROMYCIN 115 88 41 42
GABAPENTIN 109 67 43 17
SEROQUEL 109 91 43 104
PREDNISONE 105 96 45 45
HALOPERIDOL 99 87 46 133
ATENOLOL 98 84 47 14
TAMSULOSIN HCL 95 83 48 31
LEVETIRACETAM 95 64 48 55
DIOVAN 94 81 50 35
ZOLPIDEM TARTRATE 94 64 50 19
NEXIUM 88 76 52 41
LIDODERM 86 66 53 56
ADVAIR DISKUS 84 61 54 46
LANSOPRAZOLE 83 82 55 120
AMOX TR-POTASSIUM CLAVULANATE 82 55 56 110
BUMETANIDE 78 77 57 264
BENZTROPINE MESYLATE 78 64 R 57 108
ALENDRONATE SODIUM 76 48 59 28
AMIODARONE HCL 74 74 60 166
TRIAMTERENE-HCTZ 74 74 60 69
OXYCODONE HCL 72 17 S2 62 34
MEGESTROL ACETATE 71 62 R 63 236
DIVALPROEX SODIUM 70 68 64 54
NYSTATIN 68 47 65 119
FLUTICASONE PROPIONATE 67 39 66 40
PROAIR HFA 65 48 67 61
KLOR-CON M10 64 45 68 139
SYMBICORT 64 64 68 173
DILTIAZEM 24HR CD 63 61 70 146
FAMOTIDINE 63 56 70 85
POLYETHYLENE GLYCOL 3350 63 56 70 50
OLANZAPINE 61 59 73 89
HYDRALAZINE HCL 56 47 74 48
ALLOPURINOL 55 55 75 49
KLOR-CON 10 53 53 76 122
CEFUROXIME 51 45 77 171
LACTULOSE 51 29 77 67
CIPROFLOXACIN HCL 51 44 77 66
ROPINIROLE HCL 51 41 77 151
LOPERAMIDE 51 43 77 212
PROPRANOLOL HCL 51 24 77 227
LYRICA 50 39 83 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.